A: Pre-treatment enhancing adrenocortical carcinoma
B: RFA treatment needle in tumor during treatment
C: After RFA, there is no enhancement in tumor, consistent with complete tumor death
D: 3D with planes cut away showing treated tumor with close proximity of kidney, pancreas, spleen and stomach, without collateral damage
NOTE: PDF documents require the free Adobe Reader.
This page last updated on 05/24/2022
You are now leaving the NIH Clinical Center website.
This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.
The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.
More information about the NIH Clinical Center Privacy and Disclaimer policy is available at https://www.cc.nih.gov/disclaimers.html
